New diabetes clinical trial: A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Published on: September 13, 2022 at 11:00AM
Conditions:   Overweight;   Obesity;   Chronic Kidney Disease;   Type 2 Diabetes;   T2D
Interventions:   Drug: Tirzepatide;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Not yet recruiting
https://ift.tt/wzksAdQ